Eisai and Charles River Laboratories announce extension of integrated drug discovery partnership
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
List view / Grid view
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
A study by researchers at the University of Missouri School of Medicine found that the diabetes medication linagliptin can protect against stiffening of the left ventricle of the heart in overweight female mice. The finding may have implications for management of cardiovascular disease in humans.
Scientists have discovered a mechanism that provides a possible new target for allergy treatments, which may bring hope for asthma sufferers.
Targeting HER3 could cripple metastatic cancers that have spread to the brain...
A clearer picture of how the classic diabetes medication metformin works has emerged.
Researchers uncovered a new way to enhance the function of a specific type of immune cell that destroys tumours in multiple myeloma...
The Chan Zuckerberg Initiative announced financial support for the Human Cell Atlas, which uses sequencing technology to redefine every cell in the body...
SOPHiA AI demystifies the secrets of the exome, home to 85% of disease-causing genetic variants. Clinicians can now get highly accurate results to diagnose patients for rare hereditary disorders.
New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.
In adult mammal hearts, cardiomyoctyes do not proliferate following damage, like that caused by myocardial infarction.
Research in the field of kidney cancer, also called renal cancer, is vital, because many patients with this disease still cannot be cured today.
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds...
Scientists have given new superpowers to an antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections.
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.